Adult lead exposure: time for change
- PMID: 17431498
- PMCID: PMC1849904
- DOI: 10.1289/ehp.9782
Adult lead exposure: time for change
Abstract
We have assembled this mini-monograph on adult lead exposure to provide guidance to clinicians and public health professionals, to summarize recent thinking on lead biomarkers and their relevance to epidemiologic research, and to review two key lead-related outcomes, namely, cardiovascular and cognitive. The lead standards of the U.S. Occupational Safety and Health Administration are woefully out of date given the growing evidence of the health effects of lead at levels of exposure previously thought to be safe, particularly newly recognized persistent or progressive effects of cumulative dose. The growing body of scientific evidence suggests that occupational standards should limit recent dose to prevent the acute effects of lead and separately limit cumulative dose to prevent the chronic effects of lead. We hope this mini-monograph will motivate renewed discussion of ways to protect lead-exposed adults in the United States and around the world.
Comment in
-
Uncertainties in the relationship between tibia lead and cumulative blood lead index.Environ Health Perspect. 2008 Mar;116(3):A109; author reply A109-110. doi: 10.1289/ehp.10778R. Environ Health Perspect. 2008. PMID: 18335076 Free PMC article. No abstract available.
References
-
- Annest JL, Pirkle JL, Makuc D, Neese JW, Bayse DD, Kovar MG. Chronological trend in blood lead levels between 1976 and 1980. N Engl J Med. 1983;308(23):1373–1377. - PubMed
-
- AOEC 2006. Adult Lead Treatment. Washington, DC:Association of Occupational and Environmental Clinics. Available: http://www.aoec.org/principles.htm [accessed 1 December 2006].
-
- Bergdahl IA, Grubb A, Schutz A, Desnick RJ, Wetmur JG, Sassa S, et al. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol. 1997;81(4):153–158. - PubMed
-
- CDC (Centers for Disease Control and Prevention) 2004. Adult blood lead epidemiology and surveillance - United States 2002. Morb Mortal Weekly Report 53(578–582). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 ES010798/ES/NIEHS NIH HHS/United States
- R01-AG19604/AG/NIA NIH HHS/United States
- P30 ES000002/ES/NIEHS NIH HHS/United States
- R01-ES10798/ES/NIEHS NIH HHS/United States
- R01-AG10785/AG/NIA NIH HHS/United States
- R01 ES007198/ES/NIEHS NIH HHS/United States
- P30-ES00002/ES/NIEHS NIH HHS/United States
- P42-ES05947/ES/NIEHS NIH HHS/United States
- P42 ES005947/ES/NIEHS NIH HHS/United States
- R01 AG010785/AG/NIA NIH HHS/United States
- R01 ES005257/ES/NIEHS NIH HHS/United States
- R01-ES05257/ES/NIEHS NIH HHS/United States
- R01-ES07198/ES/NIEHS NIH HHS/United States
- R01 AG019604/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
